Nisa Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$51.3K Buy
1,628
+48
+3% +$1.51K ﹤0.01% 1585
2025
Q1
$51.7K Sell
1,580
-373
-19% -$12.2K ﹤0.01% 1587
2024
Q4
$70.6K Buy
1,953
+257
+15% +$9.29K ﹤0.01% 1574
2024
Q3
$52.9K Buy
1,696
+46
+3% +$1.43K ﹤0.01% 1633
2024
Q2
$44.1K Sell
1,650
-388
-19% -$10.4K ﹤0.01% 1703
2024
Q1
$69.5K Buy
2,038
+483
+31% +$16.5K ﹤0.01% 1572
2023
Q4
$45K Sell
1,555
-1,190
-43% -$34.4K ﹤0.01% 1667
2023
Q3
$75.7K Sell
2,745
-10
-0.4% -$276 ﹤0.01% 1600
2023
Q2
$82.8K Sell
2,755
-580
-17% -$17.4K ﹤0.01% 1566
2023
Q1
$121K Sell
3,335
-90
-3% -$3.27K ﹤0.01% 1454
2022
Q4
$122K Hold
3,425
﹤0.01% 1495
2022
Q3
$117K Buy
3,425
+35
+1% +$1.2K ﹤0.01% 1434
2022
Q2
$98K Buy
3,390
+750
+28% +$21.7K ﹤0.01% 1517
2022
Q1
$85K Sell
2,640
-4,003
-60% -$129K ﹤0.01% 1680
2021
Q4
$205K Buy
6,643
+2,803
+73% +$86.5K ﹤0.01% 1263
2021
Q3
$102 Buy
3,840
+100
+3% +$3 ﹤0.01% 1695
2021
Q2
$115 Buy
3,740
+290
+8% +$9 ﹤0.01% 1618
2021
Q1
$90 Hold
3,450
﹤0.01% 1796
2020
Q4
$87K Buy
3,450
+220
+7% +$5.55K ﹤0.01% 1793
2020
Q3
$67K Sell
3,230
-22,297
-87% -$463K ﹤0.01% 1684
2020
Q2
$606K Buy
25,527
+23,360
+1,078% +$555K 0.01% 954
2020
Q1
$39K Buy
2,167
+600
+38% +$10.8K ﹤0.01% 1578
2019
Q4
$37K Sell
1,567
-8,203
-84% -$194K ﹤0.01% 1583
2019
Q3
$268K Buy
9,770
+593
+6% +$16.3K ﹤0.01% 1256
2019
Q2
$304K Hold
9,177
﹤0.01% 1217
2019
Q1
$322K Buy
9,177
+8,857
+2,768% +$311K ﹤0.01% 1182
2018
Q4
$11K Hold
320
﹤0.01% 1635
2018
Q3
$16K Hold
320
﹤0.01% 1592
2018
Q2
$19K Hold
320
﹤0.01% 1546
2018
Q1
$15K Sell
320
-50
-14% -$2.34K ﹤0.01% 1538
2017
Q4
$15K Hold
370
﹤0.01% 1626
2017
Q3
$15K Hold
370
﹤0.01% 1616
2017
Q2
$16K Hold
370
﹤0.01% 1554
2017
Q1
$12K Sell
370
-330
-47% -$10.7K ﹤0.01% 1617
2016
Q4
$18K Buy
+700
New +$18K ﹤0.01% 1672